gmz2
Vaccineexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2006 (NCT00397449)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Plasmodium falciparumImmunity, active
Plasmodium falciparum immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gmz2
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00703066 | Phase 1 | Jun 1, 2008 | African Malaria Network Trust, Albert Schweitzer Hospital |
| NCT00424944 | Phase 1 | Jun 1, 2007 | African Malaria Network Trust, Albert Schweitzer Hospital |
| NCT00397449 | Phase 1 | Oct 1, 2006 | European Malaria Vaccine Initiative, University of Tuebingen |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| African Malaria Network Trust | Academic/Hospital | 2 | 2 | 1 | 2007 |
| Albert Schweitzer Hospital | Academic/Hospital | 2 | 0 | 1 | 2007 |
| European Malaria Vaccine Initiative | Academic/Hospital | 1 | 1 | 1 | 2006 |
| University of Tuebingen | Academic/Hospital | 1 | 0 | 1 | 2006 |
4 organizations
Page 1 / 1